Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs SBI Healthcare Opportunities Fund
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.1
1.99
NAV
₹25.04
₹611.08
Fund Started
06 Oct 2020
04 Jun 1999
Fund Size
₹199.62 Cr
₹5796.42 Cr
Exit Load
-
Exit load of 0.50% if redeemed within 15 days
1 Year
20.18%
20.18%
3 Year
19.49%
23.72%
5 Year
13.61%
17.71%
Equity
99.89%
96.79%
Cash
0.08%
3.16%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.99% |
Divi's Laboratories Ltd. | 6.96% |
Eli Lilly And Co | 6.34% |
Apollo Hospitals Enterprise Ltd. | 5.51% |
Max Healthcare Institute Ltd. | 4.52% |
Torrent Pharmaceuticals Ltd. | 4.45% |
Cipla Ltd. | 4.38% |
Johnson & Johnson Ltd. | 4.37% |
Laurus Labs Ltd. | 4.14% |
Dr. Reddy's Laboratories Ltd. | 3.56% |
Sun Pharmaceutical Industries Ltd. | 12.33% |
Divi's Laboratories Ltd. | 8.17% |
Apollo Hospitals Enterprise Ltd. | 4.91% |
Acutaas Chemicals Ltd. | 4.91% |
Torrent Pharmaceuticals Ltd. | 4.72% |
Cipla Ltd. | 4.67% |
Max Healthcare Institute Ltd. | 4.31% |
Laurus Labs Ltd. | 3.96% |
Aurobindo Pharma Ltd. | 3.90% |
Aster DM Quality Care Ltd. | 3.52% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
06 Oct 2020
04 Jun 1999
